Clinical Study
Histological and Immunohistochemical Revision of Hepatocellular Adenomas: A Learning Experience
Table 2
Clinical data according to hepatocellular adenoma subtypes. (The patient with both H-HCA and IHCA is not included in the table.)
| Characteristics | H-HCA | IHCA | b-HCA | Unclassified |
| Number of cases | 9 (25 %) | 20 (55.5%) | 5 (14%) | 2 (5.5%) | Age (years) | 27–68 | 17–49 | 11–42 | 28, 32 | BMI (kg/m2) | | | | | 25 | 6 | 8 | 4 | 0 | 25 | 3 (28%) | 9 (45%) | 1 (20%) | 2 (100%) | Unknown | 0 | 3 | 0 | 0 | Sex | | | | | Females | 9 | 18 | 3 | 2 | Males | 0 | 2 | 2 | 0 | Number of HCA (radiological) | | | | | Single | 4 (44.4%) | 12 (60%) | 5 (100%) | 1 (50%) | Multiple | 5 (1 adenomatosis) | 8 (2 adenomatosis) | 0 | 1 | Symptoms | | | | | Bleeding | 4 (44.4%) | 7 (35%) | 1 (20%) | 2 (100%) | Aspecific/incidental finding | 5 | 11 | 4 | 0 | Unknown | | 2 | | | OC use (32 women) | | | | | Yes | 5 (55.5%) | 10 (50%) | 2 (67%) | 2 (100%) | No | 3 | 6 | 1 | | Unknown | 1 | 2 | | | Size of lesions (mm) | 30–100 | 27–140 | 50–180 | 66–100 | Followup (range in months) | 10–129 | 10–200 | 8–120 | 24–83 | Alive without recurrence | 6 | 16 | 5 | 2 | Alive with recurrence | | | | | Alive with residual HCA | 1 | 2 | | | Unknown | 2 | 2 | | |
|
|